The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy

Leprosy Review

Volumn 81, Issue 1, 2010, Pages 27-33

  Balagon, Marivic F ^a   Cellona, Roland V ^a   Abalos, Rodolfo M ^a   Gelber, Robert H ^b   Saunderson, Paul R ^a  

^a Leonard Wood Memorial Center for Leprosy Research Philippines   (Philippines)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; OFLOXACIN; PLACEBO; PREDNISONE; RIFAMPICIN; LEPROSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; MULTICENTER STUDY; PATIENT MONITORING; PAUCIBACILLARY LEPROSY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REVERSAL REACTION; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION; DRUG COMBINATION; MICROBIOLOGY; MIDDLE AGED; RECURRENT DISEASE; SKIN; TIME; TREATMENT OUTCOME;

ADULT; DAPSONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY, PAUCIBACILLARY; MALE; MIDDLE AGED; OFLOXACIN; RECURRENCE; RIFAMPIN; SKIN; TIME FACTORS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 77953154966     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)